EVGN Evogene Ltd.
$0.48▼ -0.10%
Healthcare
Other
After hours
$0.43▼ -10.31%
Sep 11, 7:10 PM ET
Volume 2.45M
Avg Volume (10D) 62.0K
Key Metrics & Fundamentals
Market Cap
$7.59M
P/E Ratio
–
Div Yield
–%
52W Range
0.37 - 1.50
% vs 50 MA
-11.58%
% vs 200 MA
-38.37%
RSI-14
38.8
MACD Histogram
-0.0100
Beta (1Y vs SPY)
1.54
Free Cash Flow
-$1.98M
Gross Rev
$347,000
Gross Profit
$141,000
EBITDA
-$1.27M
COGS
$206,000
Operating Exp
$2.70M
Operating Income
-$2.56M
EBIT
-$2.56M
Pretax Income
-$1.59M
Net Income
-$1.77M
EPS (Diluted)
-0.14
Price & Volume History
Loading chart…
Recent News
Evogene Responds to Dissident Shareholders: Transformation and Commercial Progress Provide a Clear Path Forward
PR Newswire · Aug 31, 2026 12:00 PM
Evogene (EVGN) Q2 2026 Earnings Call Transcript
Motley Fool · Aug 25, 2026 11:45 AM
Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Evogene Ltd. Shareholders Vote "FOR" the Company's Slate of Highly Qualified Director Nominees
PR Newswire · Aug 25, 2026 11:00 AM
Evogene Ltd. Q2 2026 Earnings Call Summary
Moby · Aug 19, 2026 12:30 PM
Evogene Ltd (EVGN) (Q2 2026) Earnings Call Highlights: Strategic Pivot to AI-Driven Drug ...
GuruFocus.com · Aug 18, 2026 9:01 PM
Evogene Reports Second Quarter and First Half 2026 Financial Results
PR Newswire · Aug 18, 2026 12:04 PM
Evogene: Q2 Earnings Snapshot
Associated Press · Aug 18, 2026 11:13 AM
Cibus Inc: Interoc Expands Rice Trade to 5 Traits, 36% Revenue Growth – Quarterly Update Report
Exec Edge · Aug 17, 2026 9:50 PM
Earnings To Watch: Evogene Ltd (EVGN) Q2 2026 -- GF Value Sees 15% Downside
GuruFocus.com · Aug 17, 2026 1:17 PM
Freightos Names Yaron Eldad as Chief Financial Officer
MT Newswires · Aug 17, 2026 11:20 AM
Financial Overview - Income Statement
Quarterly
Jun 2026
See EVGN's money flow as a full page
Social Sentiment
Avg +0.60 · 1 posts
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.